XAIR Beyond Air, Inc.

$0.37 +0.91%

Healthcare · Surgical & Medical Instruments & Apparatus

Beyond Air, Inc. (XAIR) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $4 million. Shares last traded at $0.37, 92.6% below their 52-week high. Over the past year the stock is up 57.7%. Net profit margin is -1258.4%, below the peer median of -7.6%. Revenue grew 219.7% year over year.

Market Cap

$4M

Shares Out

10.5M

EPS (TTM)

$-20.49

P/E Ratio

—

P/S Ratio

1.04

P/B Ratio

0.48

Dividend / Share

—

Dividend Yield

—

52-Week High

$4.98

52-Week Low

$0.15

Volume

10,636

Avg Vol (3m)

3,939.921

Performance

-3.50%

-15.92%

-53.02%

-59.97%

YTD

-53.03%

+57.73%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

35.78

SMA (50)

$0.49

SMA (200)

$1.22

Price vs SMA50

-24.94%

Price vs SMA200

-70.04%

ATR (14)

$0.03

Financials

Revenue

$4M

Net Income

$-47M

Gross Margin

-44.9%

Operating Margin

-1202.1%

Net Margin

-1258.4%

Return on Equity

-574.8%

Return on Assets

-126.8%

Current Ratio

5.12

Debt / Equity

1.46

Revenue Growth (YoY)

+219.7%

Latest reported annual period ending 2025-03-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q3 2026	$-3.44	2026-02-13
Q2 2026	$-2.75	2025-11-10
Q1 2026	$-1.53	2025-08-12
FY 2025	$-0.69	2025-06-20
Q3 2026	$-12.77	2026-02-13
Q2 2026	$-10.99	2025-11-10

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

XAIR vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

1.04 / 2.52 med

-59% discount

Net margin vs peers

-1258.4% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.